• ChemFaces is a professional high-purity natural products manufacturer.
  • Product Intended Use
  • 1. Reference standards
  • 2. Pharmacological research
  • 3. Inhibitors
  • Home
  • Natural Products
  • Bioactive
  • Screening Libraries
  • Hot Products
  • Plant Catalog
  • Customer Support
  • Product Use Citation
  • About Us
  • Contact Us
  • Bioactive Products
    Catalog No. Information
    CFN99115 6,7-Dihydroxycoumarin

    1. 6,7-Dihydroxycoumarin has anticoagulant effect.
    2. 6,7-Dihydroxycoumarin acts as a photosensitizer for DNA damage.
    3. 6,7-Dihydroxycoumarin can quench the inner fluorescence of bovine serum albumin.
    CFN99147 Ginsenoside Ro

    1. Ginsenoside Ro shows no hemolytic nor cytotoxic activities.
    2. Ginsenoside Ro demonstrates significant anti-thrombic, anti-inflammatory, and anti-hepatitis activities in experimental models.
    CFN98007 Bavachin

    1. Bavachin is a weak antioxidant.
    2. Bavachin acts as a weak phytoestrogen by binding and activating the estrogen receptor.
    3. Bavachin stimulates bone formation and has potential activity against osteoporosis.
    4. Bavachin has antimutagenic effect, shows inhibitory activities against the antigen-induced degranulation.
    5. Bavachin has anti-inflammation effect, can protect cartilage from inflammation-mediated damage in joints of osteoarthritis patients, through decreasing IL-1 beta-induced activation of IKK-I kappaB alpha-NF-kappaB signaling pathway .
    CFN99984 Eleutheroside E

    1. Eleutheroside E has anti-inflammatory effects by inhibiting NF-κB activities.
    2. Eleutheroside E significantly decreases the inflammatory cell infiltration, pannus formation, cartilage damage, bone erosion of CIA mice, the generation of TNF-α and IL-6, the metabolism of drugs metabolized via CYP2C9 and CYP2E1.
    3. Eleutheroside E may treat rheumatoid arthritis or increase the toxicity of the drugs.
    CFN98733 Astragalin

    1. Astragalin may be a potential agent in the treatment of osteoarthritis.
    2. Astragalin can be effective in allaying ROS-promoted bronchial fibrosis through inhibiting autophagosome formation in airways.
    3. Astragalin ameliorates oxidative stress-associated epithelial eosinophilia and apoptosis through disturbing TLR4-PKCβ2-NADPH oxidase-responsive signaling.
    4. Astragalin exerts anti-inflammatory properties possibly via the inactivation of TLR4-mediated NF-κB and mitogen-activated protein kinases signaling pathways in LPS-stimulated mMECs.
    5. Astragalin exerts anti-inflammatory properties in LPS-mediated mastitis, possibly through inhibiting inhibition of the NF-κB signaling pathway, which mediates the expression of pro-inflammatory cytokines.